Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

Seminars in hematology

Volumn 23, Issue 2, 1986, Pages 132-143

  Berk, P D ^a   Goldberg, J D ^a   Donovan, P B ^a   Fruchtman, S M ^a   Berlin, N I ^a   Wasserman, L R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; HYDROXYUREA; PHOSPHORUS;

ACUTE DISEASE; AGE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; GASTROINTESTINAL TUMOR; GOUT; HEMATOCRIT; HUMAN; IATROGENIC DISEASE; LABORATORY DIAGNOSIS; LEUKEMIA; MORTALITY; MULTIMODALITY CANCER THERAPY; PHLEBOTOMY; POLYCYTHEMIA VERA; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN TUMOR; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS;

ACUTE DISEASE; AGE FACTORS; BLOODLETTING; CHLORAMBUCIL; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; FALSE POSITIVE REACTIONS; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; GOUT; HEMATOCRIT; HUMAN; HYDROXYUREA; LEUKEMIA; PHOSPHORUS RADIOISOTOPES; PLATELET AGGREGATION; PLATELET COUNT; POLYCYTHEMIA VERA; PROSPECTIVE STUDIES; PRURITUS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOSIS;

EID: 0022703490     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)